Status:
UNKNOWN
Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China
Lead Sponsor:
Shanghai Changzheng Hospital
Collaborating Sponsors:
First Affiliated Hospital of Zhejiang University
Zhongda Hospital
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the clinical outcomes and cost-effectiveness of different vascular access(arteriovenous fistula, tunneled cuffed catheter and arteriovenous graft) in the elderl...
Eligibility Criteria
Inclusion
- The elderly and very elderly with end stage renal disease.
- Estimated glomerular filtration rate (eGFR) \<20ml/min\*1.73m2
- All study subjects agree to participate in the study and provide written informed consent.
Exclusion
- Patients' life expectancy is less than 2 years.
- Mental illness that makes the patients unable to complete the trial.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02272374
Start Date
October 1 2014
End Date
December 1 2017
Last Update
October 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Changzheng Hospital
Shanghai, China, 200003